IP Library Assignment 024860/0611
Patent Assignment
Reel/Frame 024860/0611

Change of Name

Recorded: 2010-08-19 Pages: 2
Assignor
ARANA THERAPEUTICS PTY LTD
Executed: 2010-02-10
Assignee
CEPHALON AUSTRALIA PTY LTD
LEVEL 2, 37 EPPING ROAD, MACQUARIE PARK, NEW SOUTH WALES, 2113, AUSTRALIA
Covered Property (1)
Monoclonal Antibody SC104 and Derivative Thereof Specifically Binding to a Sialyltetraosyl Carbohydrate as a Potential Anti-Tumor Therapeutic Agent
Patent: 7,915,387 →
Application: 11/596,501 →
Publication: US 2008/0118509
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 13, 2007
From: DURRANT, LINDA GILLIAN; PARSONS, TINA
To: SCANCELL LIMITED
Reel/Frame 019683/0206 →
Assignment of Assignor's Interest Apr 4, 2008
From: SCANCELL LIMITED
To: ARANA THERAPEUTICS LIMITED
Reel/Frame 020758/0837 →
Conversion to a Proprietary Company Aug 19, 2010
From: ARANA THERAPEUTICS LIMITED
To: ARANA THERAPEUTICS PTY LTD
Reel/Frame 024860/0617 →
Change of Name Nov 21, 2013
From: CEPHALON AUSTRALIA PTY LTD
To: TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
Reel/Frame 031694/0287 →